Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dare Bioscience Inc

Current price
0.45 USD +0.0098 USD (+2.23%)
Last closed 0.44 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 49 156 784 USD
Yield for 12 month -53.15 %
21.11.2021 - 28.11.2021

Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older. It is developing Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia or pain during sexual intercourse; and DARE-CIN to treat cervical intraepithelial neoplasia and other human papillomavirus related pathologies. The company is also developing DARE-PDM1 for the treatment of primary dysmenorrhea; DARE-204 and DARE-214, an injectable formulations contraception of etonogestrel designed to provide contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. In addition, it is developing DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein. Daré Bioscience, Inc. is headquartered in San Diego, California. Address: 3655 Nobel Drive, San Diego, CA, United States, 92122

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price


P/E ratio

Dividend Yield

Current Year

+2 807 885 USD

Last Year

+10 000 000 USD

Current Quarter

+9 302 USD

Last Quarter

+1 807 885 USD

Current Year

+2 769 522 USD

Last Year

+10 000 000 USD

Current Quarter

-1 476 USD

Last Quarter

+1 797 905 USD

Key Figures DARE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -28 340 072 USD
Operating Margin TTM -64743.85 %
PE Ratio
Return On Assets TTM -81.78 %
PEG Ratio
Return On Equity TTM -994.69 %
Wall Street Target Price 4 USD
Revenue TTM 2 817 187 USD
Book Value -0.11 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 9 900 000 USD
Earnings per share -0.32 USD
Diluted Eps TTM -0.32 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics DARE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DARE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 20.07.2017
Dividend Date 20.07.2017

Stock Valuation DARE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 13.5909
Price Sales TTM 16.8145
Enterprise Value EBITDA -1.2349
Price Book MRQ 3.4443

Financials DARE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DARE

For 52 weeks

0.27 USD 0.98 USD
50 Day MA 0.4 USD
Shares Short Prior Month 532 880
200 Day MA 0.42 USD
Short Ratio 0.46
Shares Short 600 187
Short Percent 0.53 %

Dynamics of changes in the value of assets




441.58 USD Microsoft Corporation +0.8 (+0.18%)
Detailed analytics

ETF funds



13.85 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) -0.35 (-2.26%)
Detailed analytics



2332.52 USD Gold +27.54 (+1.2%)
Detailed analytics